Upgrade to SI Premium - Free Trial

Masimo gets FDA clearance for opioid respiratory risk detection

June 22, 2026 8:00 AM
Masimo, a Danaher company, has received FDA 510(k) clearance for an opioid-induced respiratory depression (OIRD) detection capability integrated into its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA